Monthly Archives: October 2021

Histotripsy is one such therapy that has the promise of changing cancer care

See Article: https://evtoday.com/articles/2021-oct/interventional-oncology-fast-forward-to-the-future?c4src=current:feed Histotripsy is one such therapy that has the promise of changing cancer care. It is a completely noninvasive approach akin to radiation oncology without the toxicity due to radiation and to high-intensity focused ultrasound without the problems inherent in thermal deposition in tissue with existing ablative therapies.6 The cellular destruction caused by histotripsy […]

HistoSonics Receives FDA “Breakthrough Device Designation” for Novel Sonic Beam Therapy

HistoSonics Receives FDA “Breakthrough Device Designation” for Novel Sonic Beam Therapy Breakthrough status for new histotripsy targeted liver therapy will help provide timely access to non-invasive liver treatment MINNEAPOLIS, Oct. 18, 2021 /PRNewswire/ — HistoSonics, (www.histosonics.com), the developer and manufacturer of a non-invasive platform and novel sonic beam therapy called histotripsy, announced today that the U.S. Food and […]